Aristeia Capital’s GP-Act III Acquisition Corp GPAT Stock Holding History
Bought
Maintained
Sold
Other funds holding GPAT
MI
Aristeia Capital's GPAT Position: Q2 2026 in Review
Aristeia Capital sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 490,750 shares — an estimated $5.32M sold.
Aristeia Capital first reported a position in GPAT in Q3 2024 and held it in 7 quarters. The position peaked at $5.32M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.
- Aristeia Capital reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
- Aristeia Capital sold 490,750 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $5.32M.
- Aristeia Capital first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 7 quarters.
- Aristeia Capital's GP-Act III Acquisition Corp position peaked at $5.32M in Q1 2026.
- 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.
Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.